Heigener DF et al. Topotecan/cisplatin (TP) compared to cisplatin/etoposide (PE) for patients with extensive disease-small cell lung cancer (ED-SCLC): Final results of a randomised phase III trial. Proc ASCO 2008;Abstract 7513.

Natale RB et al. S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC). Proc ASCO 2008;Abstract 7512.

Slotman B et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357(7):664-72. Abstract

Socinski MA et al. Phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaïve patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC): Interim results. Proc ASCO 2008;Abstract NSA.